Caris Life Sciences (CAI) Return on Sales (2024 - 2026)

Caris Life Sciences (CAI) posted quarterly Return on Sales of 0.0% for Q1 2026, up 1.0% year-over-year from 0.0% in Q1 2025, and down 100.84% quarter-over-quarter from 0.0% in Q4 2025.

Caris Life Sciences (CAI) Return on Sales (2024 - 2026) Analysis & Trends

Caris Life Sciences' Return on Sales history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (up 1.0% YoY), while the FY2025 annual figure was 0.0%, up 1.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
  • The five-year high for Return on Sales was 0.0% in Q4 2025, with the low at 0.01% in Q1 2025.
  • The 3-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
  • Peak annual rise in Return on Sales reached 1 bps in 2025, while the deepest fall reached 0 bps in 2025.
  • Caris Life Sciences' Return on Sales stood at 0.0% in 2024, then soared by 198 bps to 0.0% in 2025, then slumped by 101 bps to 0.0% in 2026.
  • Business Quant data shows CAI's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Caris Life Sciences 6.16 Bn 5.37 Bn 182.38 Mn 0.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 -0.01%
Dec 31, 2024 0.00%
Sep 30, 2024 -0.01%
Jun 30, 2024 -0.01%